2C-B-AN
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2C-B-AN, also known as 4-bromo-N-(α′-cyanobenzyl)-2,5-dimethoxyphenethylamine or as brolphetaminil, is a psychedelic drug of the phenethylamine, 2C, and N-benzylphenethylamine families related to 2C-B.[1][2][4] It is the derivative of 2C-B with a modified NBOMe-like N-(α′-cyanobenzyl) substitution.[1][2][4] The drug is chemically unstable and has been found to be a prodrug of 2C-B in vivo.[1][2][4] It is active at a dose of 50 mg orally and has a duration of 5 to 8 hours.[1][2][3] However, a wider dose range of 30 to 100 mg or more has also been reported.[3] 2C-B-AN has been described as producing stimulation and certain visual alterations.[1][3] It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with P. Rausch in 2009 as the source for the information.[1] 2C-B-AN was encountered as a novel designer drug in Europe by 2016.[2][3] It may be a controlled substance in Canada under phenethylamine blanket-ban language.[5] The drug is not an explicitly controlled substance in the United States.[6]
- None
| Clinical data | |
|---|---|
| Other names | 2CB-AN; 2C-B-Aminonitrile; Brolphetaminil; 4-Bromo-N-(α′-cyanobenzyl)-2,5-dimethoxyphenethylamine; 4-Bromo-N-(cyano(phenyl)methyl)-2,5-dimethoxyphenethylamine |
| Routes of administration | Oral[1][2][3] |
| Drug class | Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Metabolites | 2C-B[2][3] |
| Onset of action | 1 hour[3] |
| Duration of action | 5–8 hours[1][2][3] |
| Identifiers | |
| |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H19BrN2O2 |
| Molar mass | 375.266 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
- 2C (psychedelics)
- 25-NB
- Amphetaminil (N-(α′-cyanobenzyl)amphetamine)
- 2C-B-OH
- 25B-NBOMe